Showing results (711-720 of 834) with videos related to
Sort By:
Pageof 84
JTO Clinical and Research Reports|August 11, 2025
Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed AnalysisJay M Lee, Alessandro Brunelli, Amy L Cummings, et al.The Oncologist|September 27, 2025
Characteristics of clinical trials associated with appeal and return on investment to participants: a review and frameworkMaria J Fernandez Turizo, Maria A Velez, Beth Glenn, et al.Stem Cells (Dayton, Ohio)|October 10, 2009
CD133 expression defines a tumor initiating cell population in primary human ovarian cancerMichael D Curley, Vanessa A Therrien, Christine L Cummings, et al.Dementia and Geriatric Cognitive Disorders|September 29, 2011
Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's diseaseLiana G Apostolova, Kristy S Hwang, Luis D Medina, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 6, 2018
Genetic susceptibility to cerebrovascular disease: A systematic reviewChristoph J Griessenauer, Sean Farrell, Atom Sarkar, et al.The New England Journal of Medicine|July 21, 2021
Trial of Pimavanserin in Dementia-Related PsychosisPierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.Circulation Research|December 13, 2005
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type IDivya Seetharam, Chieko Mineo, Andrew K Gormley, et al.Journal of Alzheimer'S Disease : JAD|October 5, 2018
Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the BottleLori Frank, J Wesson Ashford, Peter J Bayley, et al.Alzheimer'S Research & Therapy|June 30, 2015
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trialsJoshua D Grill, Rema Raman, Karin Ernstrom, et al.Neurology|September 16, 2011
Chronic divalproex sodium use and brain atrophy in Alzheimer diseaseA S Fleisher, D Truran, J T Mai, et al.Pageof 84